Wensveen Maarten 4

What Happened

• Maarten Wensveen, EVP & Chief Technology Officer of Cimpress plc, exercised stock options and sold shares on May 5, 2026. He exercised 10,000 option shares at $46.20 per share (cost ~$462,000). On the same day he sold a total of 19,251 shares in multiple open-market transactions for aggregate proceeds of about $1,789,550. The filing also shows a disposition of 10,000 shares at $0.00 (derivative), which the filing treats separately from the cash exercise.

Key Details

• Transaction date: May 5, 2026; Form 4 filed May 7, 2026 (filed within the standard two-business-day window).
• Option exercise: 10,000 shares acquired at $46.20 each, total ~$462,000.
• Open-market sales (same day): 379 @ $90.73, 2,884 @ $91.73, 4,636 @ $92.39, 9,797 @ $93.49, 1,555 @ $94.13 — total sold = 19,251 shares; total proceeds ≈ $1,789,550.
• Reported weighted-average price notes: actual sale prices ranged across the transactions:
  • F1: $90.59–$90.85 (weighted avg shown $90.73)
  • F2: $91.41–$91.99 (weighted avg shown $91.73)
  • F3: $92.01–$92.97 (weighted avg shown $92.39)
  • F4: $93.00–$93.97 (weighted avg shown $93.49)
  • F5: $94.00–$94.79 (weighted avg shown $94.13)
• Shares owned after the transactions: not specified in the information provided in this summary.
• Footnote F6: the option vests over time (25% at initial exercisable date, then 6.25% each fiscal quarter thereafter).

Context

• This filing shows an option exercise coupled with immediate open-market sales. That pattern frequently reflects routine option-exercise and liquidity activity rather than a straightforward buy or sell signal; the filing also includes a zero-dollar disposition of 10,000 shares (derivative), which commonly represents net-share settlement or withholding related to the exercise. The filing does not indicate a 10b5-1 plan or gift; no late filing was indicated.